Cancer Research AACR Membership Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, K.
Right arrow Articles by Dinney, C. P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inoue, K.
Right arrow Articles by Dinney, C. P. N.
[Cancer Research 60, 2290-2299, April 15, 2000]
© 2000 American Association for Cancer Research

Tumor Biology

Interleukin 8 Expression Regulates Tumorigenicity and Metastasis in Human Bladder Cancer1

Keiji Inoue, Joel W. Slaton, Sun Jin Kim, Paul Perrotte, Beryl Y. Eve, Menashe Bar-Eli, Robert Radinsky and Colin P. N. Dinney2

Departments of Cancer Biology [K. I., J. W. S, S. J. K., B. Y. E., M. B-E., R. R., C. P. N. D.] and Urology [P. P., C. P. N. D.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Interleukin 8 (IL-8) is mitogenic and chemotactic for endothelial cells. Within a neoplasm, IL-8 is secreted by inflammatory and neoplastic cells. The highly tumorigenic and highly metastatic human transitional cell carcinoma (TCC) cell line 253J B-V overexpresses IL-8 relative to the nontumorigenic and nonmetastatic 253J-P cell line. To determine whether IL-8 expression regulates tumorigenicity and metastasis in human TCC, 253J B-V cells were transfected with the full-sequence antisense (AS) cDNA for IL-8, whereas 253J-P cells were transfected with the full-length IL-8 cDNA, and control cells for each were transfected with the neomycin resistance (Neo) gene. In vitro, sense-transfected 253J-P cells overexpressed IL-8-specific mRNA and protein, whereas both of these were markedly reduced in AS-IL-8-transfected 253J B-V cells relative to controls. Moreover, sense-transfected cells showed up-regulation in matrix metalloproteinase type 9 mRNA, collagenase activity, and increased invasiveness through Matrigel-coated filters, whereas these measures were lower in AS-transfected cells relative to controls. After implantation into the bladders of athymic nude mice, the sense-transfected 253J-P cells acquired increased tumorigenicity and metastasis, whereas the AS-transfected cells significantly inhibited tumorigenicity and metastases in the 253J B-V cell lines. This effect was accompanied by reduced IL-8 expression and microvessel density. These studies demonstrate that IL-8 expression enhances angiogenic activity through the induction of matrix metalloproteinase type 9 and subsequently regulates the tumorigenesis and production of spontaneous metastases of human TCC.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
D. J.J. Waugh and C. Wilson
The Interleukin-8 Pathway in Cancer
Clin. Cancer Res., November 1, 2008; 14(21): 6735 - 6741.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
Y. Lu, J. Wang, Y. Xu, A. E. Koch, Z. Cai, X. Chen, D. L. Galson, R. S. Taichman, and J. Zhang
CXCL16 Functions as a Novel Chemotactic Factor for Prostate Cancer Cells In vitro
Mol. Cancer Res., April 1, 2008; 6(4): 546 - 554.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
C. F. MacManus, J. Pettigrew, A. Seaton, C. Wilson, P. J. Maxwell, S. Berlingeri, C. Purcell, M. McGurk, P. G. Johnston, and D. J.J. Waugh
Interleukin-8 Signaling Promotes Translational Regulation of Cyclin D in Androgen-Independent Prostate Cancer Cells
Mol. Cancer Res., July 1, 2007; 5(7): 737 - 748.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Huang, A. Lavoie-Lamoureux, K. Moran, and J.-P. Lavoie
IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells
Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1147 - L1154.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Zhao, M.-J. Kwon, S. Huang, J. Y. Lee, K. Fukase, N. Inohara, and D. H. Hwang
Differential Modulation of Nods Signaling Pathways by Fatty Acids in Human Colonic Epithelial HCT116 Cells
J. Biol. Chem., April 20, 2007; 282(16): 11618 - 11628.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. P. Mitra, R. H. Datar, and R. J. Cote
Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target Identification
J. Clin. Oncol., December 10, 2006; 24(35): 5552 - 5564.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. M. Myers-Irvin, T.-S. Van Le, and R. H. Getzenberg
Mechanistic Analysis of the Role of BLCA-4 in Bladder Cancer Pathobiology
Cancer Res., August 15, 2005; 65(16): 7145 - 7150.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. S. Doubrovina, M. M. Doubrovin, E. Vider, R. B. Sisson, R. J. O'Reilly, B. Dupont, and Y. M. Vyas
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma
J. Immunol., December 15, 2003; 171(12): 6891 - 6899.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. E. De Larco, B. R. K. Wuertz, D. Yee, B. L. Rickert, and L. T. Furcht
Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells
PNAS, November 25, 2003; 100(24): 13988 - 13993.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. M. Mian, C. P. N. Dinney, C. E. Bermejo, P. Sweeney, C. Tellez, X. D. Yang, J. M. Gudas, D. J. McConkey, and M. Bar-Eli
Fully Human Anti-Interleukin 8 Antibody Inhibits Tumor Growth in Orthotopic Bladder Cancer Xenografts via Down-Regulation of Matrix Metalloproteases and Nuclear Factor-{kappa}B
Clin. Cancer Res., August 1, 2003; 9(8): 3167 - 3175.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Karashima, P. Sweeney, A. Kamat, S. Huang, S. J. Kim, M. Bar-Eli, D. J. McConkey, and C. P. N. Dinney
Nuclear Factor-{kappa}B Mediates Angiogenesis and Metastasis of Human Bladder Cancer through the Regulation of Interleukin-8
Clin. Cancer Res., July 1, 2003; 9(7): 2786 - 2797.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. Lu, Y. Nakamoto, Y. Nemoto-Sasaki, C. Fujii, H. Wang, M. Hashii, Y. Ohmoto, S. Kaneko, K. Kobayashi, and N. Mukaida
Potential Interaction between CCR1 and Its Ligand, CCL3, Induced by Endogenously Produced Interleukin-1 in Human Hepatomas
Am. J. Pathol., April 1, 2003; 162(4): 1249 - 1258.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Levy, C. Neuveut, C.-A. Renard, P. Charneau, S. Branchereau, F. Gauthier, J. T. Van Nhieu, D. Cherqui, A.-F. Petit-Bertron, D. Mathieu, et al.
Transcriptional Activation of Interleukin-8 by beta -Catenin-Tcf4
J. Biol. Chem., October 25, 2002; 277(44): 42386 - 42393.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Wang, E. Gjernes, and H. Prydz
Factor VIIa Induces Tissue Factor-dependent Up-regulation of Interleukin-8 in a Human Keratinocyte Line
J. Biol. Chem., June 21, 2002; 277(26): 23620 - 23626.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Inoue, M. Kamada, J. W. Slaton, S. Fukata, C. Yoshikawa, P. Tamboli, C. P. N. Dinney, and T. Shuin
The Prognostic Value of Angiogenesis and Metastasis-related Genes for Progression of Transitional Cell Carcinoma of the Renal Pelvis and Ureter
Clin. Cancer Res., June 1, 2002; 8(6): 1863 - 1870.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
I. Feoktistov, A. E. Goldstein, S. Ryzhov, D. Zeng, L. Belardinelli, T. Voyno-Yasenetskaya, and I. Biaggioni
Differential Expression of Adenosine Receptors in Human Endothelial Cells: Role of A2B Receptors in Angiogenic Factor Regulation
Circ. Res., March 22, 2002; 90(5): 531 - 538.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. Van Coillie, I. Van Aelst, A. Wuyts, R. Vercauteren, R. Devos, C. De Wolf-Peeters, J. Van Damme, and G. Opdenakker
Tumor Angiogenesis Induced by Granulocyte Chemotactic Protein-2 as a Countercurrent Principle
Am. J. Pathol., October 1, 2001; 159(4): 1405 - 1414.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
J. E. De Larco, B. R. K. Wuertz, J. C. Manivel, and L. T. Furcht
Progression and Enhancement of Metastatic Potential after Exposure of Tumor Cells to Chemotherapeutic Agents
Cancer Res., April 1, 2001; 61(7): 2857 - 2861.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
K. Inoue, J. W. Slaton, T. Karashima, C. Yoshikawa, T. Shuin, P. Sweeney, R. Millikan, and C. P. N. Dinney
The Prognostic Value of Angiogenesis Factor Expression for Predicting Recurrence and Metastasis of Bladder Cancer after Neoadjuvant Chemotherapy and Radical Cystectomy
Clin. Cancer Res., December 1, 2000; 6(12): 4866 - 4873.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
I. Feoktistov, A. E. Goldstein, S. Ryzhov, D. Zeng, L. Belardinelli, T. Voyno-Yasenetskaya, and I. Biaggioni
Differential Expression of Adenosine Receptors in Human Endothelial Cells: Role of A2B Receptors in Angiogenic Factor Regulation
Circ. Res., March 22, 2002; 90(5): 531 - 538.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.